Related Experiment Video
Updated: Sep 12, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
490
Streamlining Psoriatic Arthritis Screening and Management Using the IDEOM Clinical Framework: A Quality Improvement
Journal of Drugs in Dermatology : JDD
|August 7, 2025
Summary
This quality improvement initiative improved psoriatic arthritis (PsA) screening and assessment in dermatology clinics. The framework facilitated timely rheumatology referrals, leading to a higher rate of PsA diagnosis and better patient management.
Area of Science:
- Dermatology and Rheumatology
- Clinical Quality Improvement
- Patient Outcomes
Background:
- Psoriatic arthritis (PsA) is frequently undiagnosed, leading to irreversible joint damage.
- Early screening and assessment are crucial for timely intervention and improved patient outcomes.
- A quality improvement initiative was implemented to enhance PsA detection and management in dermatology settings.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of a clinical framework for PsA screening and assessment.
- To integrate validated screening tools into routine dermatology practice.
- To improve the rate of rheumatology referrals and subsequent diagnosis for patients with PsA.
Main Methods:
- Implementation of the Psoriasis Epidemiology Screening Tool (PEST) and Psoriatic Arthritis Impact of Disease (PsAID-12) questionnaire into electronic medical records across 26 dermatology clinics.
- PsA screening for Psoriasis (PsO) patients using PEST, with positive screens or existing PsA diagnoses proceeding to PsAID-12 completion.
- Utilizing PsAID-12 scores to guide management decisions, including treatment adjustments and rheumatology referrals for scores exceeding a defined threshold.
Main Results:
- Over 27 months, 37.2% of eligible PsO patients completed the PEST, with 12.5% scoring ≥3 and completing the PsAID-12.
- 75.7% of patients completing the PsAID-12 had scores ≤4, indicating effective disease management.
- Among patients scoring >4 on the PsAID-12, 24.7% were referred to rheumatology, and 44.4% received a subsequent PsA diagnosis. A significant reduction in average PsAID-12 scores was observed in patients assessed twice.
Conclusions:
- The integrated clinical framework is feasible for optimizing PsA screening and assessment in dermatology settings.
- The initiative demonstrated success in identifying undiagnosed PsA and facilitating appropriate rheumatology referrals.
- The study highlights the potential to improve the quality of care for patients with psoriasis and suspected psoriatic arthritis.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:21Methods of Documentation III: PIE
1.5K
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
1.5K
01:15Methods of Documentation VI: Case Management Model
628
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
628
01:21Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
58
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58